CVS Health Corp., US1266501006

CVS Health expands fall assortment. CVS Health stock costs EUR 83.68.

Published on 10/24/2026 at 10:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVS Health stock costs EUR 83.68 in weekend trading on October 24, 2026. The Xetra close was EUR 83.84 on October 23, 2026.

Dates and retail developments

  • On October 23, 2026, CVS Pharmacy announced expanded fall offerings across multiple retail categories and cited approximately 9,000 pharmacy locations.
  • CVS Health stock trades in weekend trading at Lang & Schwarz at EUR 83.68 at 10:36 a.m. CEST on October 24, 2026, 0.19 percent below the Xetra close of October 23, 2026.
  • The next Xetra session is scheduled for October 26, 2026.
CVS Health Corp. Flatlay-Arrangement mit Aktienzertifikat, Stethoskop und pharmazeutischen Medikamenten, ISIN US1266501006, Illustration mit AI erstellt.

Market context: Market report S&P 500.

On October 23, 2026, CVS Pharmacy, the retail division of CVS Health, announced an expanded fall assortment of collectibles, nostalgic favorites, limited-edition products and seasonal items across CVS Pharmacy stores and CVS.com, according to the CVS Health newsroom. Separately, CVS Health stock trades in weekend trading at Lang & Schwarz at EUR 83.68 at 10:36 a.m. CEST on October 24, 2026, EUR 0.16 or 0.19 percent below the Xetra close of October 23, 2026, at EUR 83.84.

The week in figures

CVS Health's official newsroom describes the company as having approximately 9,000 retail pharmacy locations as of June 30, 2026. The October 24, 2026, weekend-trading price at Lang & Schwarz is EUR 83.68, compared with the Xetra close of EUR 83.84 on October 23, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of CVS Health stock.

Chronology of the week

On October 23, 2026, CVS Pharmacy announced new and expanded offerings including Pokémon trading cards, blind-box collectibles, beauty products and seasonal snacks. The company said product availability varies by location and while supplies last. The announcement was published by the CVS Health newsroom.

On October 15, 2026, CVS Health announced a collaboration with The Midlife Collective to conduct a research study on women's midlife experiences. The findings are intended to inform the documentary Her Second Act, according to the company's investor-relations release.

Dates of the coming week

The next Xetra session is scheduled for October 26, 2026. CVS Health's third-quarter 2026 earnings conference call is scheduled for November 4, 2026, at 8:00 a.m. Eastern Time, according to an investor-relations notice.

Disclaimer...
en | US1266501006 | CVS HEALTH CORP. | boerse | 70403698 | bgmi